{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T19:10:08Z","timestamp":1648840208192},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00101-018-0419-4","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T10:10:15Z","timestamp":1519639815000},"page":"275-279","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Abortiver Verlauf einer malignen Hyperthermie nach pr\u00e4klinischer Narkoseinduktion mit Succinylcholin"],"prefix":"10.1007","volume":"67","author":[{"given":"D.","family":"Helf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schneiderbanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. K.","family":"Markus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Johannsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"419_CR1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.clinbiochem.2017.02.016","volume":"12","author":"G Cervellin","year":"2017","unstructured":"Cervellin G, Comelli I, Benatti M et al (2017) Non-traumatic rhabdomyolysis: background, laboratory features, and acute clinical management. Clin Biochem 12:656\u2013662","journal-title":"Clin Biochem"},{"key":"419_CR2","first-page":"483","volume":"49","author":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin","year":"2008","unstructured":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin (2008) Empfehlung zur Therapie der malignen Hyperthermie (revidierte Version 2008) erstellt durch Roewer N, Schuster F, Wappler F. An\u00e4sth Intensivmed 49:483\u2013488","journal-title":"An\u00e4sth Intensivmed"},{"key":"419_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/bja\/aev225","volume":"115","author":"PM Hopkins","year":"2015","unstructured":"Hopkins PM, Ruffert H, Snoeck MM et\u00a0al (2015) European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility. Br J Anaesth 115:531\u2013539","journal-title":"Br J Anaesth"},{"key":"419_CR4","unstructured":"http:\/\/www.Awmf.Org\/Uploads\/Tx_Szleitlinien\/001-030l_S1_Praehospitale_Notfallnarkose_Erwachsene_2015-03.Pdf\n                    \n                   (2015). Zugegriffen: 30. Jan. 2018"},{"key":"419_CR5","unstructured":"https:\/\/Www.Gelbe-Liste.De\/Produkte\/Rocuronium-Inresa-10-Mg-Ml-Injektionsloesung-Infusionsloesung_534425.Zugegriffen\n                    \n                  . Zugegriffen: 30. Jan. 2018"},{"key":"419_CR6","first-page":"12","volume-title":"Maligne Hyperthermie und assoziierte Erkrankungen in An\u00e4sthesie und Intensivmedizin","author":"S Johannsen","year":"2016","unstructured":"Johannsen S, Schuster F (2016) Maligne Hyperthermie in der Intensivmedizin. In: Klingler W (Hrsg) Maligne Hyperthermie und assoziierte Erkrankungen in An\u00e4sthesie und Intensivmedizin. Thieme, Stuttgart, S\u00a012\u201318"},{"key":"419_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/oxfordjournals.bja.a013590","volume":"84","author":"AS Laurence","year":"2000","unstructured":"Laurence AS (2000) Serum myoglobin and creatine kinase following surgery. Br J Anaesth 84:763\u2013766","journal-title":"Br J Anaesth"},{"key":"419_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1186\/s13023-015-0310-1","volume":"10","author":"H Rosenberg","year":"2015","unstructured":"Rosenberg H, Pollock N, Schiemann A et\u00a0al (2015) Malignant hyperthermia: a\u00a0review. Orphanet J Rare Dis 10:939","journal-title":"Orphanet J Rare Dis"},{"key":"419_CR9","first-page":"467","volume":"34","author":"J Warszawska","year":"2016","unstructured":"Warszawska J, Raimann F, Ippolito A et\u00a0al (2016) Muskelrelaxanzien in der An\u00e4sthesie und Intensivmedizin. Arzneimitteltherapie 34:467\u2013477","journal-title":"Arzneimitteltherapie"},{"key":"419_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00101-014-2351-6","volume":"63","author":"S Wolak","year":"2014","unstructured":"Wolak S, Rucker B, Kohlschmidt N et\u00a0al (2014) Homozygous and compound heterozygous RYR1 mutations. New findings on prevalence and penetrance of malignant hyperthermia. Anaesthesist 63:643\u2013650","journal-title":"Anaesthesist"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-018-0419-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-018-0419-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-018-0419-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T01:39:20Z","timestamp":1551145160000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-018-0419-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1007\/s00101-018-0419-4","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"11 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Schuster erh\u00e4lt Referentenhonorar von der Firma Norgine GmbH. D.\u00a0Helf, D.\u00a0Schneiderbanger, C.K.\u00a0Markus und S.\u00a0Johannsen geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. Alle Patienten, die \u00fcber Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}